Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 26 2019

Full Issue

Prestigious Consulting Firm McKinsey Thrust Into Spotlight Over Advice It Gave To Drugmakers At Height Of Opioid Crisis

Court cases over the opioid epidemic are putting an embarrassing spotlight on McKinsey's strategic advice that's usually kept strictly behind a curtain. One lawsuit stated that McKinsey advised a pharmaceutical company to “get more patients on higher doses of opioids” and study techniques “for keeping patients on opioids longer.” In other news on the epidemic: Sen. Rob Portman (R-Ohio) rails against companies that he says have hurt Americans through the crisis, the Massachusetts attorney general is investigating a pharmacy over improper prescriptions for opioids, and more.

The New York Times: McKinsey Advised Johnson & Johnson On Increasing Opioid Sales

At the global consulting firm McKinsey & Company, the rule is sacrosanct: Never publicly disclose client advice. And for the most part, adherence to that rule has served the company well. But in recent months, as government officials seek to assign blame for the opioid crisis that has strangled large parts of the nation, McKinsey’s advice is surfacing in ways that are deeply embarrassing for the influential firm, whose clients include many of the world’s most admired companies. One lawsuit stated that McKinsey advised a pharmaceutical company to “get more patients on higher doses of opioids” and study techniques “for keeping patients on opioids longer.” (Bogdanich, 7/25)

The Washington Post: Rob Portman Says Drug Companies Should Be Required To Help Those Hurt By Opioids

Sen. Rob Portman (R-Ohio) said drug companies responsible for distributing billions of opioids to Americans, leading to an epidemic of addictions and overdose deaths, should be required to help those hurt by the drug. On the Senate floor on Thursday, Portman delivered a lengthy speech in response to The Washington Post’s investigation that revealed drug companies were able to circulate 76 billion pain pills from 2006 to 2012. (Itkowitz, 7/25)

WBUR: Mass. AG Healey Is Investigating Andover-Based Pharmacy's Opioid Prescriptions

The Massachusetts attorney general is investigating an Andover-based pharmacy for potentially improperly prescribing opioids to customers. Injured Workers Pharmacy (IWP) is a home delivery pharmacy that works with attorneys on worker’s compensation claims and personal injury lawsuits across the country. (Willmsen, 7/25)

Nashville Tennessean: More Than 250K Dirty Syringes Collected In Nashville After Law Change

Eighteen months ago, in a van parked on a city street corner, a heroin user dropped a syringe into a red plastic box marked with a hazardous waste warning. Nashville had gathered its first dirty needle. Since then, more than 250,000 used syringes were collected by Street Works, the city’s only syringe exchange program. The Street Works exchange operates five days a week from a roving van, handing out clean needles and collecting dirty ones. (Kelman, 7/25)

Miami Herald: Opioid Crisis Brought 5.5 Billion Pills To Florida

In a seven-year span that saw an opioid epidemic reach crisis levels, 5,556,553,071 hydrocodone and oxycodone pills flooded into Florida.They poured across the state through shady clinics that became known as “pill mills.” But hundreds of millions streamed through grocery stores and chain pharmacies like CVS and Walgreens, according to newly released data provided by the Drug Enforcement Agency to The Washington Post and analyzed by the Herald/Times. (Mahoney and Taylor, 7/25)

Arizona Republic: Millions Of Opioid Pills Flowed From Arizona Pharmacies

A small independent pharmacy called Uptown Drug dispensed 5.6 million hydrocodone and oxycodone pills in this northwest Arizona city from 2006 to 2012. That's almost 200 pills per resident. (Hinkle, 7/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF